이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Windlas Biotech 관리

관리 기준 확인 2/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

Komal Gupta

최고 경영자

n/a

총 보상

CEO 급여 비율	n/a
CEO 임기	8.8yrs
CEO 소유권	n/a
경영진 평균 재임 기간	4.3yrs
이사회 평균 재임 기간	4.1yrs

최근 관리 업데이트

Recent updates

Even With A 27% Surge, Cautious Investors Are Not Rewarding Windlas Biotech Limited's (NSE:WINDLAS) Performance Completely

Jun 07

Is Now The Time To Put Windlas Biotech (NSE:WINDLAS) On Your Watchlist?

Nov 03

Windlas Biotech (NSE:WINDLAS) Is Increasing Its Dividend To ₹4.00

Aug 20

Windlas Biotech (NSE:WINDLAS) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

May 23

Windlas Biotech Limited's (NSE:WINDLAS) Shares Lagging The Market But So Is The Business

Apr 07

CEO

Komal Gupta

8.8yrs

테뉴어

Ms. Komal Gupta is the Chief Financial Officer of Windlas Biotech Limited since October 16, 2015 and serves as its Chief Executive Office since February 08, 2023. She joined Windlas Biotech on October 16,...

리더십 팀

이름	위치	테뉴어	보상	소유권
Ashok Windlass	Whole-Time Director	no data	₹15.60m	62.51% ₹ 9.3b
Hitesh Windlass	MD & Executive Director	4.3yrs	₹14.70m	0.000010% ₹ 1.5k
Manoj Windlass	Joint MD & Executive Director	4.3yrs	₹14.70m	0.000030% ₹ 4.5k
Pawan Sharma	Executive Director	no data	₹4.61m	데이터 없음
Komal Gupta	CFO & CEO	8.8yrs	데이터 없음	데이터 없음
Ananta Panda	Company Secretary & Compliance Officer	3.3yrs	데이터 없음	데이터 없음
Mohammed Aslam	President of Sales & Marketing	no data	데이터 없음	데이터 없음
Om Sule	Site Quality Head	4.6yrs	데이터 없음	데이터 없음

4.3yrs

평균 재임 기간

55.5yo

평균 연령

경험이 풍부한 관리: WINDLAS 의 관리팀은 경험 ( 4.2 년 평균 재직 기간)으로 간주됩니다.

이사회 구성원

이름	위치	테뉴어	보상	소유권
Ashok Windlass	Whole-Time Director	23.4yrs	₹15.60m	62.51% ₹ 9.3b
Hitesh Windlass	MD & Executive Director	16.5yrs	₹14.70m	0.000010% ₹ 1.5k
Manoj Windlass	Joint MD & Executive Director	18.3yrs	₹14.70m	0.000030% ₹ 4.5k
Pawan Sharma	Executive Director	5.1yrs	₹4.61m	데이터 없음
Gaurav Gulati	Non-Executive Independent Director	3.2yrs	데이터 없음	데이터 없음
Vivek Dhariwal	Non-Executive Independent Chairman	3.2yrs	데이터 없음	데이터 없음
Srinivasan Venkataraman	Non-Executive Independent Director	3.2yrs	데이터 없음	데이터 없음
Prachi Windlass	Non-Executive Director	3.2yrs	데이터 없음	0.000010% ₹ 1.5k

4.1yrs

평균 재임 기간

49yo

평균 연령

경험이 풍부한 이사회: WINDLAS 의 이사회는 경험(평균 재직 기간 4 년)으로 간주됩니다.

Windlas Biotech 관리

관리 기준 확인 2/4

주요 정보

최근 관리 업데이트

Windlas Biotech Limited, Annual General Meeting, Sep 12, 2023

Windlas Biotech Limited Appoints Komal Gupta as the Chief Executive Officer

Less than half of directors are independent

Windlas Biotech Limited, Annual General Meeting, Sep 19, 2022

Less than half of directors are independent

Less than half of directors are independent

Recent updates

Even With A 27% Surge, Cautious Investors Are Not Rewarding Windlas Biotech Limited's (NSE:WINDLAS) Performance Completely

Full year 2024 earnings released: EPS: ₹27.97 (vs ₹19.70 in FY 2023)

Now 21% overvalued after recent price rise

Windlas Biotech Limited to Report Q4, 2024 Results on May 20, 2024

Now 21% overvalued after recent price rise

Now 23% overvalued after recent price rise

Now 21% overvalued after recent price rise

New minor risk - Share price stability

Now 20% overvalued after recent price rise

Third quarter 2024 earnings released: EPS: ₹7.26 (vs ₹4.23 in 3Q 2023)

Windlas Biotech Limited to Report Q3, 2024 Results on Feb 08, 2024

Windlas Biotech Limited to Report Q3, 2024 Results on Feb 08, 2024

Investor sentiment improves as stock rises 22%

Second quarter 2024 earnings released: EPS: ₹6.75 (vs ₹5.59 in 2Q 2023)

Is Now The Time To Put Windlas Biotech (NSE:WINDLAS) On Your Watchlist?

Windlas Biotech Limited to Report First Half, 2024 Results on Nov 08, 2023

Windlas Biotech Limited Approves Final Dividend for the Financial Year 2022-23

Upcoming dividend of ₹4.00 per share at 1.1% yield

Windlas Biotech (NSE:WINDLAS) Is Increasing Its Dividend To ₹4.00

Windlas Biotech Limited, Annual General Meeting, Sep 12, 2023

Investor sentiment improves as stock rises 16%

First quarter 2024 earnings released: EPS: ₹5.79 (vs ₹4.50 in 1Q 2023)

Windlas Biotech Limited to Report Q1, 2024 Results on Aug 08, 2023

Full year 2023 earnings released: EPS: ₹19.70 (vs ₹18.58 in FY 2022)

Windlas Biotech Limited Recommends Dividend

Windlas Biotech Limited Appoints Komal Gupta as the Chief Executive Officer

Third quarter 2023 earnings released: EPS: ₹4.23 (vs ₹3.81 in 3Q 2022)

Less than half of directors are independent

Windlas Biotech Limited (BSE:543329) announces an Equity Buyback for INR 250 million worth of its shares.

Second quarter 2023 earnings released: EPS: ₹5.59 (vs ₹4.11 in 2Q 2022)

Windlas Biotech Limited Declares A Final Dividend for the Financial Year 2021-22

Windlas Biotech Limited Proposes Final Dividend for the Financial Year 2021-22

Windlas Biotech Limited, Annual General Meeting, Sep 19, 2022

First quarter 2023 earnings released: EPS: ₹4.50 (vs ₹3.67 in 1Q 2022)

Windlas Biotech Limited to Report Q1, 2023 Results on Aug 04, 2022

Windlas Biotech (NSE:WINDLAS) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

The Board of Directors of Windlas Biotech Limited, At Their Meeting Held on May 12, 2022, Approves the Dividend of INR 3.5 Per Share

Less than half of directors are independent

Investor sentiment improved over the past week

Windlas Biotech Limited's (NSE:WINDLAS) Shares Lagging The Market But So Is The Business

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

First quarter 2022 earnings released: EPS ₹3.67 (vs ₹0.25 in 1Q 2021)

Investor sentiment improved over the past week

Less than half of directors are independent

CEO

테뉴어

리더십 팀

평균 재임 기간

평균 연령

이사회 구성원

평균 재임 기간

평균 연령